Zoetis Belgium SA
Pharmaceutical ManufacturingWallonia, Belgium201-500 Employees
Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways.
Market Position Zoetis Belgium SA operates in the specialized animal health sector with a strong regional presence in Belgium, providing opportunities to expand within the European market by leveraging its global brand reputation.
Growth Potential With a revenue range of 10 to 25 million dollars and a dedicated team of 201-500 employees, there is significant scope for upselling advanced veterinary products and services as the company scales.
Digital Engagement The company's adoption of a diverse tech stack, including analytics and website optimization tools, indicates an openness to digital channels, presenting sales opportunities through targeted online campaigns and data-driven outreach.
Industry Trends Operating alongside competitors like Elanco and Virbac, Zoetis is positioned within a competitive market that is increasingly focused on innovation and sustainability, opening avenues for introducing next-generation animal health solutions.
Partnership Opportunities Given its focus on animal health and a medium-sized workforce, Zoetis is likely to welcome collaborations, joint ventures, or supply chain partnerships with companies offering complementary technologies or products.
Zoetis Belgium SA uses 8 technology products and services including Visual Website Optimizer, MobX, core-js, and more. Explore Zoetis Belgium SA's tech stack below.
| Zoetis Belgium SA Email Formats | Percentage |
| First.Last@zoetis.com | 96% |
| FLast@zoetis.com | 2% |
| FirstLast@zoetis.com | 1% |
| Last.First@zoetis.com | 1% |
Pharmaceutical ManufacturingWallonia, Belgium201-500 Employees
Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways.
Zoetis Belgium SA's revenue is estimated to be in the range of $10M$25M
Zoetis Belgium SA's revenue is estimated to be in the range of $10M$25M